ResMed Inc. 

(Public, NYSE:RMD)   Watch this stock   
Find more results for RMD
Dec 2, 2009
Piper Jaffray Healthcare Conference - 9:00AM EST - Add to calendar
Nov 17, 2009
Shareholders Meeting
Nov 11, 2009
Credit Suisse Healthcare Conference - Webcast
Nov 5, 2009
Q1 2010 Earnings Conference Call - Webcast
Nov 5, 2009
Q1 2010 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference
Sep 15, 2009
Morgan Stanley Global Healthcare Unplugged Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 17.05% 15.91%
Operating margin 21.32% 20.53%
EBITD margin - 26.33%
Return on average assets 10.80% 10.05%
Return on average equity 14.57% 13.33%
Employees 2,900 -

Address

14040 Danielson Street
Poway, CA 92064
United States - Map
+1-858-7462400 (Phone)
+1-858-6222043 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

ResMed Inc. discussed on blogs

Ranking 700+ Mid-Cap Stocks by Profit Margin - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

ResMed Inc. discussions

  View all discussions »

Description

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Officers and directors

Peter C. Farrell Ph.D.
Executive Chairman of the Board
Age: 67
Bio & Compensation - Reuters
Kieran T. Gallahue
President, Chief Executive Officer, Director
Age: 47
Bio & Compensation - Reuters
Brett Sandercock
Chief Financial Officer
Age: 42
Bio & Compensation - Reuters
David Pendarvis
Sr. Vice President - Organizational Development, Global General Counsel, Corporate Secretary
Age: 50
Bio & Compensation - Reuters
Robert D. Douglas
Chief Operating Officer, Asia Pacific
Age: 49
Bio & Compensation - Reuters
Stein Jacobsen
Chief Operating Officer, Europe
Age: 44
Bio & Compensation - Reuters
Christopher Graham Roberts Ph.D.
Director
Age: 55
Bio & Compensation - Reuters
Gary W. Pace Ph.D.
Director
Age: 61
Bio & Compensation - Reuters
Michael A. Quinn
Director
Age: 61
Bio & Compensation - Reuters
John P. Wareham
Director
Age: 68
Bio & Compensation - Reuters